Home
Aarti Pharmalabs Ltd Quarterly Result

Aarti Pharmalabs Ltd
NSE: AARTIPHARMA
Net Profit - Last Quarter
Aarti Pharmalabs Ltd Quarterly Results Key Highlights
- The revenue of Aarti Pharmalabs Ltd for the Dec '24 is ₹ 542.81 crore as compare to the Sep '24 revenue of ₹ 462.51 crore.
- This represent the growth of 17.36%a1# The ebitda of Aarti Pharmalabs Ltd for the Dec '24 is ₹ 133.64 crore as compare to the Sep '24 ebitda of ₹ 98.16 crore.
- This represent the growth of 36.15%a1# The net profit of Aarti Pharmalabs Ltd for the Dec '24 is ₹ 73.99 crore as compare to the Sep '24 net profit of ₹ 54.62 crore.
- This represent the growth of 35.46%a1#.
Aarti Pharmalabs Ltd Quarterly Results Analysis
Market Price of Aarti Pharmalabs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 764 |
20 Feb 2025 | 780.1 |
19 Feb 2025 | 802.55 |
18 Feb 2025 | 807.7 |
17 Feb 2025 | 789.55 |
14 Feb 2025 | 720 |
13 Feb 2025 | 733.45 |
12 Feb 2025 | 741.7 |
11 Feb 2025 | 718.3 |
10 Feb 2025 | 738.7 |
Historical Revenue of Aarti Pharmalabs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Aarti Pharmalabs Ltd
Historical EBITDA of Aarti Pharmalabs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Aarti Pharmalabs Ltd
Historical Net Profit of Aarti Pharmalabs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aarti Pharmalabs Ltd
Aarti Pharmalabs Ltd News Hub
Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter
Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 2024 as again
Read more
05 Aug 24
Aarti Pharmalabs to discuss results
Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 October 2024. Po
Read more
22 Oct 24
Aarti Pharmalabs consolidated net profit rises 5.44% in the September 2024 quarter
Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as a
Read more
28 Oct 24
Aarti Pharmalabs Company Secretary resigns
Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the position o
Read more
28 Oct 24